ERBB2 and breast carcinoma: Zhang et al. proposed the co-delivery of 5-fluorodeoxyuridine and DOX via AuNPs equipped with affibody–DNA hybrid strands to achieve a synergistic effect for the treatment of HER2 overexpressing breast cancer [17].